SKI Market

Indian Indices

Nifty

24,008.00 -265.80
(-1.10%)

Sensex

79,454.47 -880.34
( -1.10%)

Bank Nifty

53,595.25 -770.40
( -1.42%)

Nifty IT

35,880.10 -122.35
( -0.34%)

Global Indices

Nasdaq

41,266.30 -123.15
(-0.30%)

Dow Jones

5,680.75 -4.19
(-0.07%)

Hang Seng

37,492.25 563.62
(1.53%)

Nikkei 225

8,554.80 23.19
(0.27%)

Forex

USD-INR

85.39 0.69
(0.81%)

EUR-INR

96.28 0.21
(0.22%)

GBP-INR

113.48 0.52
(0.46%)

JPY-INR

0.59 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Viji Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

537820

INE159N01027

1.5010526

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIJIFIN

213

30.35

EPS(TTM)

Face Value()

Div & Yield %

0.01

Back

osiajee texfab ltd

Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter

Feb 11,2025

Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	23.56	22.11	7
OPM %	23.47	19.13	-
PBDT	5.17	3.94	31
PBT	5.01	3.75	34
NP	5.05	3.68	37

24,008.00 -265.80 (-1.10%)

79,454.47 -880.34 ( -1.10%)

53,595.25 -770.40 ( -1.42%)

35,880.10 -122.35 ( -0.34%)

41,266.30 -123.15 (-0.30%)

5,680.75 -4.19 (-0.07%)

37,492.25 563.62 (1.53%)

8,554.80 23.19 (0.27%)

85.39 0.69 (0.81%)

96.28 0.21 (0.22%)

113.48 0.52 (0.46%)

0.59 0.00 (-0.21%)